Cardiovascular diseases

2024 Activity indicators

  • 2 competitive European projects led: RETENTION (H2020) y STRATIFY-HF (HE)
  • 6 national public projects led: ISCIII, MICINN
  • 9 private projects led
  • 54 clinical trials led
  • 95 publications
  • IF: 808.37
  • Q1 publications: 59 (62%)
  • D1 publications: 37 (39%)
  • 3 thesis
  • 2 awards/recognitions
  • Members of editorial committees: 5 researchers
  • 1 international patent (EP11845312,5) "Possible use of EMMPRIN inhibitors for the treatment of cardiac damage after ischemia-reperfusion" (Authors: Dr. Carlos Zaragoza et al.) and another in application phase

Milestones

  1. First European Lump Sum financing project awarded "FH-EARLY 101155885: New strategies for the EARLY diagnosis, risk stratification and co-management of familial hypercholesterolemia".
  2. CIBER - SPANISH I study. Prospective, randomized, multicenter, open-label, event-driven study to evaluate the non-inferiority of a personalized precision strategy for the prevention of sudden death in patients with non-ischemic dilated cardiomyopathy. PI in our center: Dr. Marta Jiménez-Blanco.
  3. First European project of the ERASMUS program awarded. "XiA: Xpanding Innovative Alliance for interoperability skills in digital health".
  4. Dr. Cristina Lozano appointed President of the Young Cardiologists Group of the Spanish Society of Cardiology.
  5. Dr. Zamorano obtains various appointments and recognitions, including: Academician of the Royal National Academy of Medicine of Spain, Director of the European PCR TRICUSPID Focus Group, Co-Director of the Interventional Echocardiography Congress (Milan, 2024).

Bibliometrics

  Articles Accum. IF Mean IF Articles Q1 or Q2 % in Q1 or Q2 Articles D1 % in D1
2020 87 372.38 4.28 48 55 14 16
2021 95 637.15 6.71 73 77 20 21
2022 102 999.40 9.80 74 73 30 29
2023 83 567.62 6.60 64 74 15 17
2024 95 808.37 8.51 69 73 37 39
  465 3384.92 7.18 328 71 116 25

* Only original articles, editorials, guidelines and reviews 

Networks and alliances